Bromocriptine/cabergoline/oxcarbazepine interaction: Reduced clinical efficacy leading to prolactinoma progression (first report of an interaction between cabergoline and oxcarbazepine): case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1416, 2012-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cabergoline: SUNCT syndrome in a patient with prolactinoma: case report

By  

Reactions Weekly, Vol. 1, Iss. 1136, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Aripiprazole/lithium/oxcarbazepine: Priapism (first report with aripiprazole and oxcarbazepine): case report

By  

Reactions Weekly, Vol. 1, Iss. 1091, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Oxcarbazepine/valproate semisodium interaction: Increased serum valproate concentrations: case report

By  

Reactions Weekly, Vol. 1, Iss. 1212, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Oxcarbazepine/sertraline interaction: Fatal serotonin syndrome in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1417, 2012-01 ,pp. : 35-36

Adis International

Access to resources Recommend Favorite

Oxcarbazepine: First report of hepatic adenoma: case report

By  

Reactions Weekly, Vol. 1, Iss. 1204, 2008-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite